[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350826-105":59,"doc-detail-350826-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinicopathological-and-genetic-analysis-of-primary-intraosseous-carcinoma-not-otherwise-specified-pioc-nos","Clinicopathological and genetic analysis of primary intraosseous carcinoma not otherwise specified (PIOC NOS)","","Primary intraosseous carcinoma not otherwise specified (PIOC NOS) is an extremely rare jawbone cancer, representing about 1–2% of oral cancers. Owing to its rarity, no established standard exists for managing postoperative recurrence or metastasis. This study analyzes clinical features and explores novel genomic abnormalities, supporting improved identification and informing potential targeted treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinicopathological-and-genetic-analysis-of-primary-intraosseous-carcinoma-not-otherwise-specified-pioc-nos/350826/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinicopathological-and-genetic-analysis-of-primary-intraosseous-carcinoma-not-otherwise-specified-pioc-nos/350826.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is primary intraosseous carcinoma not otherwise specified (PIOC NOS)?","Question",{"text":112,"@type":113},"PIOC NOS is a central jaw odontogenic carcinoma that cannot be categorized as another odontogenic carcinoma type, and it is defined as a squamous cell carcinoma originating within the jawbone.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is there no standard treatment for PIOC NOS postoperative recurrence or metastasis?",{"text":117,"@type":113},"PIOC NOS is extremely rare, so there is insufficient evidence to establish a unified standard approach for recurrence or metastasis management.",{"name":119,"@type":110,"acceptedAnswer":120},"How was genomic information analyzed in this study?",{"text":121,"@type":113},"Genomic analysis was performed on seven formalin-fixed paraffin-embedded surgical specimens using next-generation sequencing across 523 DNA and 55 RNA cancer-related genes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350826,1790673804,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Yasuda et al. BMCOral Health (2026) 26:1730 BMC Oral Health  \n[https://doi.org/10.1186/s12903-026-09040-9](https://doi.org/10.1186/s12903-026-09040-9)  \nRESEARCH Open Access  \nClinicopathological and genetic analysis of primary intraosseous carcinoma not otherwise specified (PIOC NOS)  \nSachiko Yasuda1,2, Kaori Oya3, Shoko Ikuta1, So Takata1, Yoichiro Nakatani1,4, Yasushi Totoki1, Narikazu Uzawa2*† and Shinichi Yachida1,5,6*†  \nAbstract  \nBackground Primary intraosseous carcinoma not otherwise specified (PIOC NOS) is an extremely rare jawbone cancer, accounting for approximately 1–2% of all oral cancers. Considering its rarity, no established standard treatment exists for postoperative recurrence or metastasis. This study aimed to analyse the clinical manifestations of this disease and identify novel genomic abnormalities to aid identification of potential treatment strategies.  \nMethods We examined the clinical information of 14 PIOC NOS cases treated at our institution in recent years and compared it with previous reports. Genomic analysis was conducted on seven formalin-fixed paraffin-embedded surgical specimens, assessing 523 DNA and 55 RNA cancer-related genes using next-generation sequencing.  \nResults Our findings, along with previous literature, revealed the posterior mandible as the primary site in most cases, though this was rarely identified at the time of initial diagnosis. Recurrence within two years of surgery was common. Hotspot mutations in PIK3CA were observed in 60% of cases. Additionally, one patient had high TMB status. Conclusions Given the challenges in diagnosis and the potential for rapid recurrence or metastasis, early detection is crucial. Comprehensive genomic profiling is highly desirable, as genomic analysis may direct the development of targeted therapeutic agents to treat relapse.  \nKeywords PIOC NOS, Oral cancer, Squamous cell carcinoma, Next-generation sequencing, Genetic analysis  \n†Narikazu Uzawa and Shinichi Yachida are the last two authors contributed equally as co-corresponding authors.  \n*Correspondence:  \nNarikazu Uzawa [uzawa. narikazu.dent@osaka-u.ac.jp](uzawa. narikazu.dent@osaka-u.ac.jp)[ ](uzawa. narikazu.dent@osaka-u.ac.jp)Shinichi Yachida[syachida@cgi.med.osaka-u.ac.jp](syachida@cgi.med.osaka-u.ac.jp)  \n1Department of Cancer Genome Informatics, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan  \n2Department of Oral & Maxillofacial Oncology and Surgery, Graduate School of Dentistry, The University of Osaka, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan  \n3Division of Clinical Laboratory, The University of Osaka Dental Hospital, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan  \n4Department of Biological Informatics, Laboratory of Medical and Evolutionary Genomics, Bioinformatics Center, Research Institute for Microbial Diseases, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan  \n5Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), The University of Osaka, Suita, Osaka 565-0871, Japan  \n6Japan Agency for Medical Research and Development – Core Research for Evolutional Science and Technology (AMED–CREST), 1-7-1 Otematchi, Chiyoda-ku, Tokyo 100-0004, Japan  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line","cbCaid29rXASMPia","https://ap.wps.com/l/cbCaid29rXASMPia","pdf",1862964,11,"English","# Abstract\n# Introduction\n## Diagnostic criteria and clinical features\n## Imaging characteristics and histopathology\n## Treatment implications","[{\"question\":\"What is primary intraosseous carcinoma not otherwise specified (PIOC NOS)?\",\"answer\":\"PIOC NOS is a central jaw odontogenic carcinoma that cannot be categorized as another odontogenic carcinoma type, and it is defined as a squamous cell carcinoma originating within the jawbone.\"},{\"question\":\"Why is there no standard treatment for PIOC NOS postoperative recurrence or metastasis?\",\"answer\":\"PIOC NOS is extremely rare, so there is insufficient evidence to establish a unified standard approach for recurrence or metastasis management.\"},{\"question\":\"How was genomic information analyzed in this study?\",\"answer\":\"Genomic analysis was performed on seven formalin-fixed paraffin-embedded surgical specimens using next-generation sequencing across 523 DNA and 55 RNA cancer-related genes.\"}]","Clinicopathological and genetic analysis of primary intraosseous carcinoma not otherwise specified (PIOC NOS) | PDF",1790091338,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de80269b1c5a3eed24d72088cbc2086f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be5ea245266cd37a8e4c4c9ba23a8b89.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f07ff07e1e46eb83c6f4d45e3b318081.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c830079ab28c2753d39e7dce8cf45886.webp",980,1306]